Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Duramed Research
Duramed Research
Industry · 24 registered clinical trials.
Status
Trial
Phase
Started
Completed
A Multicenter Study to Evaluate the Effects of a 91-day Oral Contraceptive on Bone Mineral Density in Adolesce
Bone Mineral Density
Phase 2
2009-06-01
Completed
A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Rel
Migraine
Phase 2
2009-01-01
Completed
Emergency Contraception Actual Use Study
Emergency Contraception
Phase 3
2008-10-01
Completed
A Safety Extension Study of DR-OXY-301
Overactive Bladder
Phase 3
2008-09-01
Completed
A Clinical Trial to Evaluate the Efficacy and Safety of DR-3001 in Women With Overactive Bladder
Overactive Bladder
Phase 3
2008-05-01
Completed
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
Infertility
Phase 3
2008-02-01
Completed
Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in
Nocturnal Vasomotor Symptoms
Phase 4
2007-12-01
Completed
A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to Seasonale
Breakthrough Bleeding
Phase 2
2006-10-01
Completed
A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
Respiratory Tract Diseases
Phase 3
2006-09-01
Completed
Open-Label Study to Evaluate the Safety and Efficacy of a Low-Dose 28-Day Oral Contraceptive
Contraception
Phase 3
2006-08-01
Completed
A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatme
Menopause
Phase 3
2006-08-01
Completed
A Clinical Trial to Demonstrate the Efficacy and Safety of Cenestin 0.3 mg for the Treatment of Hot Flashes
Hot Flashes
Phase 3
2005-12-01
Completed
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
Amenorrhea
Phase 2
2005-09-01
Withdrawn
Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
Osteopenia
Phase 3
2005-07-01
Completed
A Study to Evaluate Suppression of the Pituitary-Ovarian Axis With Three Different Oral Contraceptive Regimens
Healthy
Phase 3
2005-06-01
Completed
Comparison of DR-2011 to a Progesterone Vaginal Gel for Luteal Phase Replacement
Infertility
Phase 2
2005-06-01
Completed
Evaluation of DR-2001 for the Management of Endometriosis-Related Pelvic Pain
Endometriosis
Phase 2
2005-06-01
Completed
A Clinical Trial to Study DR-2031 for the Treatment of Hot Flashes in Prostate Cancer Patients
Prostate Cancer
Phase 2
2005-06-01
Completed
Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral Contracep
Contraception
Phase 3
2005-06-01
Completed
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Dysmenorrhea
Phase 2
2005-05-01
Completed
A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic Pain
Dysmenorrhea
Phase 3
2005-01-01
Completed
A Clinical Trial to Evaluate the Safety and Efficacy of Enjuvia 0.3 mg for the Treatment of Vulvovaginal Atrop
Menopause
Phase 3
2004-11-01
Completed
Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder
Urinary Incontinence
Phase 2
2004-10-01
Completed
A Multicenter Study to Evaluate the Safety of Seasonique, an Oral Contraceptive.
Contraception
Phase 3
2003-05-01